Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,556 | 1,173 | 99.7% |
| Education | $60.57 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,436 | 155 | $0 (2024) |
| Lilly USA, LLC | $1,851 | 128 | $0 (2024) |
| PFIZER INC. | $1,789 | 119 | $0 (2024) |
| Novo Nordisk Inc | $1,768 | 102 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,756 | 117 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,430 | 76 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,375 | 105 | $0 (2024) |
| Merck Sharp & Dohme LLC | $957.60 | 65 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $938.02 | 68 | $0 (2023) |
| ABBVIE INC. | $871.45 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,620 | 136 | Lilly USA, LLC ($414.92) |
| 2023 | $2,552 | 140 | ABBVIE INC. ($332.15) |
| 2022 | $2,627 | 159 | ABBVIE INC. ($377.16) |
| 2021 | $2,614 | 160 | GlaxoSmithKline, LLC. ($431.66) |
| 2020 | $2,150 | 133 | GlaxoSmithKline, LLC. ($347.29) |
| 2019 | $2,121 | 151 | GlaxoSmithKline, LLC. ($429.00) |
| 2018 | $1,957 | 152 | AstraZeneca Pharmaceuticals LP ($276.97) |
| 2017 | $1,976 | 152 | AstraZeneca Pharmaceuticals LP ($312.49) |
All Payment Transactions
1,183 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $54.86 | General |
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $34.02 | General |
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Obesity | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $47.56 | General |
| 10/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 528 | 654 | $78,995 | $41,887 |
| 2022 | 17 | 647 | 848 | $101,706 | $54,261 |
| 2021 | 13 | 538 | 619 | $71,985 | $41,939 |
| 2020 | 17 | 653 | 764 | $75,866 | $47,837 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $23,500 | $11,711 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 144 | $18,720 | $11,680 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 110 | $11,550 | $6,424 | 55.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 18 | $5,400 | $3,854 | 71.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,750 | $1,775 | 64.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $1,680 | $1,570 | 93.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $1,350 | $1,299 | 96.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 54 | 54 | $1,350 | $1,160 | 85.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 20 | 40 | $5,120 | $863.48 | 16.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 20 | 40 | $5,120 | $705.18 | 13.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 50 | $2,000 | $436.41 | 21.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $400.00 | $367.50 | 91.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 11 | 11 | $55.00 | $42.90 | 78.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 182 | $23,660 | $13,996 | 59.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $24,750 | $12,629 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 85 | $8,925 | $4,717 | 52.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 17 | $5,100 | $3,537 | 69.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 25 | 25 | $3,500 | $3,297 | 94.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 30 | 81 | $10,368 | $3,280 | 31.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 30 | 81 | $10,368 | $3,084 | 29.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 15 | $3,075 | $2,431 | 79.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $3,250 | $2,151 | 66.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 51 | 52 | $1,300 | $1,252 | 96.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 51 | 52 | $1,300 | $1,073 | 82.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 34 | 34 | $850.00 | $839.25 | 98.7% |
About Dr. Scott Phillips, M.D
Dr. Scott Phillips, M.D is a Internal Medicine healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003840513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Phillips, M.D has received a total of $18,616 in payments from pharmaceutical and medical device companies, with $2,620 received in 2024. These payments were reported across 1,183 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($18,556).
As a Medicare-enrolled provider, Phillips has provided services to 2,366 Medicare beneficiaries, totaling 2,885 services with total Medicare billing of $185,925. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pittsburgh, PA
- Active Since 07/10/2006
- Last Updated 06/17/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003840513
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,399
- JARDIANCE (Drug) $1,364
- ELIQUIS (Drug) $1,204
- XARELTO (Drug) $824.34
- Ozempic (Drug) $756.89
- FARXIGA (Drug) $723.53
- TRULICITY (Drug) $647.25
- CHANTIX (Drug) $549.82
- MOUNJARO (Drug) $527.72
- SOLIQUA 100/33 (Biological) $465.45
- VRAYLAR (Drug) $356.47
- SPRAVATO (Drug) $347.82
- UBRELVY (Drug) $322.04
- STIOLTO RESPIMAT (Drug) $317.60
- TRADJENTA (Drug) $304.70
- ANORO (Drug) $295.72
- JANUVIA (Drug) $291.66
- SYMBICORT (Drug) $279.98
- Kerendia (Drug) $244.91
- QULIPTA (Drug) $235.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pittsburgh
Christopher Gisler, Md, MD
Internal Medicine — Payments: $978,960
Dr. Joshua Silverstein, M.d, M.D
Internal Medicine — Payments: $472,100
Brian Henry, Md, MD
Internal Medicine — Payments: $207,815
Meilin Young, Md, MD
Internal Medicine — Payments: $155,901
Dr. Enrico Novelli, M.d, M.D
Internal Medicine — Payments: $114,138
Bassel Sayegh, M.d, M.D
Internal Medicine — Payments: $98,056